Clinical Trials Browser

Interventional × Has results × Cystadenocarcinoma, Serous × Clear all

Adenocarcinoma, Mucinous, Carcinosarcoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Cystadenocarcinoma, Serous

NCT03673124 2025-12-23

Ribociclib and Letrozole Treatment in Ovarian Cancer

Phase 2 Active not recruiting

51 enrolled 19 charts

Cystadenocarcinoma, Serous

NCT02101788 2025-11-13

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Phase 2/3 Completed

260 enrolled 20 charts

Cystadenocarcinoma, Serous

NCT00551070 2020-12-03

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

Phase 2 Completed

52 enrolled 11 charts

Cystadenocarcinoma, Serous

NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

Phase 2 Completed

30 enrolled 5 charts

Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

Clinical Trials

A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Ribociclib and Letrozole Treatment in Ovarian Cancer

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

Papillary Serous Carcinoma of the Endometrium